Verona Pharma PLC Holding(s) in Company (1162E)
May 03 2017 - 1:02PM
UK Regulatory
TIDMVRP TIDMAV.
RNS Number : 1162E
Verona Pharma PLC
03 May 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or Verona Pharma plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
--------------------------------------------------------------- ------------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
-----------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
------------------------------------------------------------------ ---------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------------ ---------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------------------ ---------------------------------------
An event changing the breakdown of voting rights
------------------------------------------------------------------ ---------------------------------------
Other (please
specify):
----------------------------------------------------------- ----- ---------------------------------------
3. Full name of person(s) Aviva plc & its subsidiaries
subject to the
notification obligation:
(iii)
------------------------------------------------------------- --------------------------------------------
4. Full name of shareholder(s) Registered Holder:
(if different from 3.):(iv)
HSBC Global Custody Nominee
(UK) Limited 501,275*
Chase (GA Group) Nominees
Limited 1,292,033*
State Street Nominees Limited
63,903*
Available on request 2,482*
*denotes direct interest
Chase (GA Group) Nominees
Limited 233,235
Chase Nominees Limited 62,166
Vidacos Nominees Limited 323,354
------------------------------------------------------------- --------------------------------------------
5. Date of the transaction 28 April 2017
and date on
which the threshold is
crossed or
reached: (v)
------------------------------------------------------------- --------------------------------------------
6. Date on which issuer 2 May 2017
notified:
------------------------------------------------------------- --------------------------------------------
7. Threshold(s) that is/are 5% to 3% Change at Direct
crossed or Interest Level (Box 8A) &
reached: (vi, vii) 7% to <5% Change at Combined
Interest Level (Box 8A)
------------------------------------------------------------- --------------------------------------------
8. Notified details:
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
--------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------------ ------------------------------- ---------------------------------------------------------
Number Number Number Number of voting % of voting
of of of shares rights rights (x)
Shares Voting
Rights
------------------ ----------------- ------------ ------------ ---------------------- -------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------------ ----------------- ------------ ------------ ---------- ---------- ------- ----------
Ordinary
Shares
GB00B06GSH43 181,042,592 181,042,592 2,478,448 1,859,693 618,755 3.62% 1.20%
----------------- ------------ ------------ ---------- ---------- ------- ----------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion rights that rights
(xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
------------------ ----------------- -------------------------- ---------------------- -------------------
800,000*
RIGHT TO RECALL
LOANED SHARES N/A N/A *Direct Interest 1.56%
------------------ ----------------- -------------------------- ---------------------- -------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
-----------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights (xix,
(xvii) period refers to xx)
(xviii)
------------------ --------- ----------- ------------ ------------------- ----------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- -------- ------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
3,278,448 6.38%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
-----------------------------------------------------------------
The voting rights are managed and controlled by Aviva
Investors Global Services Limited and Friends Provident
International Limited, with the following chain of controlled
undertakings:-
Aviva Investors Global Services Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Investors Holdings Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Aviva Investors Global Services Limited (wholly owned
subsidiary of Aviva Investors Holdings Limited)
Friends Provident International Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Friends Provident International Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
Proxy Voting:
-----------------------------------------------------------------
10. Name of the proxy holder: See Section 4
---------------------------------------------- -----------------
11. Number of voting rights proxy
holder will cease
to hold:
---------------------------------------------- -----------------
12. Date on which proxy holder will
cease to hold
voting rights:
---------------------------------------------- -----------------
Figures are based on a total
13. Additional information: number of voting rights of
51,361,064, as per the Company's
Total Voting Rights and Block
Listing Interim Review Announcement
of 13 February 2017.
------------------------------- -------------------------------------
14. Contact name: Neil Whittaker, Aviva plc
------------------------------- -------------------------------------
15. Contact telephone number: 01603 684420
------------------------------- -------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUGUBAAUPMGQW
(END) Dow Jones Newswires
May 03, 2017 13:02 ET (17:02 GMT)
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jul 2023 to Jul 2024
